139 related articles for article (PubMed ID: 36028796)
1. Age- and sex-based changes in spike protein antibody status after SARS-CoV-2 vaccination and effect of past-infection in healthcare workers in Osaka.
Hoshida S; Koeda N; Hattori H; Tanaka M; Tanaka I; Fukui H; Fujita J; Sasaki Y; Tamura S
BMC Infect Dis; 2022 Aug; 22(1):709. PubMed ID: 36028796
[TBL] [Abstract][Full Text] [Related]
2. Serological Screening of Immunoglobulin G against SARS-CoV-2 Nucleocapsid and Spike Protein before and after Two Vaccine Doses among Healthcare Workers in Japan.
Hiramoto S; Miyashita D; Kimura T; Niwa T; Uchida A; Sano M; Murata M; Nagasawa T; Tsunekawa K; Aoki T; Yoshida A; Kato T; Yanagisawa K; Tokue Y; Murakami M
Tohoku J Exp Med; 2022 May; 257(1):57-64. PubMed ID: 35354694
[TBL] [Abstract][Full Text] [Related]
3. SARS-CoV-2 Spike and Nucleocapsid Antibody Response in Vaccinated Croatian Healthcare Workers and Infected Hospitalized Patients: A Single Center Cohort Study.
Brlić PK; Pavletić M; Lerga M; Krstanović F; Matešić MP; Miklić K; Malić S; Mikša L; Pajcur M; Peruč D; Schubert M; Bertoglio F; Arapović J; Protić A; Šustić A; Milošević M; Šain LČ; Jonjić S; Lisnić VJ; Brizić I
Viruses; 2022 Sep; 14(9):. PubMed ID: 36146773
[TBL] [Abstract][Full Text] [Related]
4. Serological response in health care workers after a single dose of SARS-CoV-2 vaccine using six automated SARS-CoV-2 antibody assays.
Cuykx M; Mortelé O; Jansens H; Schouwers S; Meskal A; Hoffbauer I; Peeters B
Diagn Microbiol Infect Dis; 2021 Oct; 101(2):115486. PubMed ID: 34332306
[TBL] [Abstract][Full Text] [Related]
5. Mild SARS-CoV-2 Illness Is Not Associated with Reinfections and Provides Persistent Spike, Nucleocapsid, and Virus-Neutralizing Antibodies.
Schuler CF; Gherasim C; O'Shea K; Manthei DM; Chen J; Zettel C; Troost JP; Kennedy AA; Tai AW; Giacherio DA; Valdez R; Baldwin JL; Baker JR
Microbiol Spectr; 2021 Oct; 9(2):e0008721. PubMed ID: 34468184
[TBL] [Abstract][Full Text] [Related]
6. SARS COV-2 anti-nucleocapsid and anti-spike antibodies in an emergency department healthcare worker cohort: September 2020 - April 2021.
Wang RC; Murphy CE; Kornblith AE; Hohenstein NA; Carter CM; Wong AHK; Kurtz T; Kohn MA
Am J Emerg Med; 2022 Apr; 54():81-86. PubMed ID: 35144108
[TBL] [Abstract][Full Text] [Related]
7. Healthcare Workers in South Korea Maintain a SARS-CoV-2 Antibody Response Six Months After Receiving a Second Dose of the BNT162b2 mRNA Vaccine.
Choi JH; Kim YR; Heo ST; Oh H; Kim M; Lee HR; Yoo JR
Front Immunol; 2022; 13():827306. PubMed ID: 35173736
[TBL] [Abstract][Full Text] [Related]
8. Spike Antibody Titers Evaluation after a 2-Dose Regimen of BNT162b2 Vaccination in Healthcare Workers Previously Infected with SARS-CoV-2.
Kayukawa S; Nanya K; Morita M; Ina K; Ota Y; Hasegawa S
Microbiol Spectr; 2021 Dec; 9(3):e0103621. PubMed ID: 34756062
[No Abstract] [Full Text] [Related]
9. [Investigation of SARS-CoV-2-Specific Humoral and Cellular Immunity Values in Health Care Workers with COVID-19 Disease and Administered with COVID-19 Vaccine].
Keskin AÜ; Dalan AB; Çıragil P; Topkaya AE
Mikrobiyol Bul; 2022 Jul; 56(3):480-492. PubMed ID: 35960239
[TBL] [Abstract][Full Text] [Related]
10. BNT162b2 COVID-19 vaccine and correlates of humoral immune responses and dynamics: a prospective, single-centre, longitudinal cohort study in health-care workers.
Lustig Y; Sapir E; Regev-Yochay G; Cohen C; Fluss R; Olmer L; Indenbaum V; Mandelboim M; Doolman R; Amit S; Mendelson E; Ziv A; Huppert A; Rubin C; Freedman L; Kreiss Y
Lancet Respir Med; 2021 Sep; 9(9):999-1009. PubMed ID: 34224675
[TBL] [Abstract][Full Text] [Related]
11. Time course of antibody concentrations against the spike protein of SARS-CoV-2 among healthy hospital workers up to 200 days after their first COVID-19 vaccination.
Mueller T
J Clin Lab Anal; 2022 Jan; 36(1):e24175. PubMed ID: 34910338
[No Abstract] [Full Text] [Related]
12. Dominant CD8
Taus E; Hofmann C; Ibarrondo FJ; Hausner MA; Fulcher JA; Krogstad P; Ferbas KG; Tobin NH; Rimoin AW; Aldrovandi GM; Yang OO
Front Immunol; 2022; 13():835830. PubMed ID: 35273611
[TBL] [Abstract][Full Text] [Related]
13. The Comparability of Anti-Spike SARS-CoV-2 Antibody Tests is Time-Dependent: a Prospective Observational Study.
Perkmann T; Mucher P; Perkmann-Nagele N; Radakovics A; Repl M; Koller T; Schmetterer KG; Bigenzahn JW; Leitner F; Jordakieva G; Wagner OF; Binder CJ; Haslacher H
Microbiol Spectr; 2022 Feb; 10(1):e0140221. PubMed ID: 35196824
[TBL] [Abstract][Full Text] [Related]
14. Coronavirus Vaccination: Spike Antibody Levels in Health Workers after Six Months-A Cross-Sectional Study.
Damerau L; Mühlenbruch G; Evenschor-Ascheid A; Fussen C; Nienhaus A; Terschüren C; Herold R; Harth V
Int J Environ Res Public Health; 2022 Sep; 19(18):. PubMed ID: 36141696
[TBL] [Abstract][Full Text] [Related]
15. Factors associated with anti-severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) spike protein antibody titer and neutralizing activity among healthcare workers following vaccination with the BNT162b2 vaccine.
Kobashi Y; Shimazu Y; Kawamura T; Nishikawa Y; Omata F; Kaneko Y; Kodama T; Tsubokura M
PLoS One; 2022; 17(6):e0269917. PubMed ID: 35687563
[TBL] [Abstract][Full Text] [Related]
16. Response and Duration of Serum Anti-SARS-CoV-2 Antibodies After Inactivated Vaccination Within 160 Days.
Xu QY; Xue JH; Xiao Y; Jia ZJ; Wu MJ; Liu YY; Li WL; Liang XM; Yang TC
Front Immunol; 2021; 12():786554. PubMed ID: 35003104
[TBL] [Abstract][Full Text] [Related]
17. Comprehensive characterization of the antibody responses to SARS-CoV-2 Spike protein finds additional vaccine-induced epitopes beyond those for mild infection.
Garrett ME; Galloway JG; Wolf C; Logue JK; Franko N; Chu HY; Matsen FA; Overbaugh JM
Elife; 2022 Jan; 11():. PubMed ID: 35072628
[TBL] [Abstract][Full Text] [Related]
18. Humoral and cellular response to SARS-CoV-2 BNT162b2 mRNA vaccine in hemodialysis patients.
Melin J; Svensson MK; Albinsson B; Winqvist O; Pauksens K
BMC Immunol; 2021 Oct; 22(1):70. PubMed ID: 34666683
[TBL] [Abstract][Full Text] [Related]
19. Factors associated with anti-SARS-CoV-2 spike antibody titers after a second BNT162b2 mRNA COVID-19 vaccination in Japanese hemodialysis patients.
Hirai K; Shimotashiro M; Sonoda T; Okumura T; Ookawara S; Morishita Y
Clin Exp Nephrol; 2022 Sep; 26(9):925-932. PubMed ID: 35426594
[TBL] [Abstract][Full Text] [Related]
20. Comparison of SARS-CoV-2 anti-spike receptor binding domain IgG antibody responses after CoronaVac, BNT162b2, ChAdOx1 COVID-19 vaccines, and a single booster dose: a prospective, longitudinal population-based study.
Barin B; Kasap U; Selçuk F; Volkan E; Uluçkan Ö
Lancet Microbe; 2022 Apr; 3(4):e274-e283. PubMed ID: 35165669
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
